WeightWatchers (WW International) stock is experiencing a significant surge on Wednesday, driven by the company’s announcement of adding compounded semaglutide to its weight-loss offerings. This move comes in response to widespread shortages and insurance hurdles for GLP-1 medications like Wegovy and Ozempic.